Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite surges for obesity drugmakers Eli Lilly and Novo Nordisk. But the sector is off to a healthy start in 2025.

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other healthcare stocks.

However, its low valuation could have investors wondering if now is the right time to take a chance on the business, especially before it releases its year-end earnings numbers on Feb. 12. Let's take a look at whether CVS could potentially be an underrated buy right now.

Rhode Island-based CVS Health Corporation (CVS) offers pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. With a market cap of $72.